Connect - CardioFocus · asymptomatic atrial fibrillation and atrial fibrillation in heart failure Carmeliet-Coraboeuf-Weidmann lecture Management of patients with atrial fibrillation:

With the participation of the ESC Working Groups on e-Cardiology and Grown-up Congenital Heart Disease and in conjunction with the 41st Annual Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology.

EURO

PAC

E

CARDIOSTIM18-21 June

Vienna, Austria

www.escardio.org/EUROPACE #ehraeuropace

Connect

ADVANCE PROGRAMME

1

Welcome Address

Join EHRA in Vienna for EHRA EUROPACE – CARDIOSTIM 2017

EHRA EUROPACE – CARDIOSTIM 2017 promises to be a highly successful congress!

The EHRA Scientific Programme Committee has developed a compelling programme designed to provide

attendees with the latest in science and education in the field of cardiac rhythm disorders and therapies.

During this four days congress, highly acclaimed scientific sessions will cover all aspects of pacing and

electrophysiology. Delegates will also have the chance to discover new research, learn from world

renowned experts and exchange with colleagues and peers.

Dedicated sessions for allied professionals, young electrophysiologists, and women in electrophysiology

will be delivered and once again, the congress will be joined by colleagues from the ESC Working Groups

on e-Cardiology and on Grown-up Congenital Heart Disease as well as the 41st Annual Meeting on

Cardiac Cellular Electrophysiology.

We look forward to welcoming you to the beautiful city of Vienna, and making this congress another

success!

Prof. Michael GliksonEHRA Scientific Programme Chairperson

Prof. Helmut PuererfellnerEHRA Scientific Programme Vice-Chairperson

Dr. Arnaud Lazarus Cardiostim Scientific Programme Chairperson

Prof. Pierre Jais Cardiostim Scientific Programme Vice-Chairperson

Dr. Philippe Ritter Cardiostim Past President

2 3

Scientific Programme Committees

Abstract ChairsDr. Alessandro Proclemer (IT) Dr. Roy Beinart (IL)

AF SummitDr. Christopher Piorkowski (DE)

Allied Professionals Dr. Jenny Tagney (GB) Prof. Donna Fitzsimons (GB) Mrs. Lynne Hinterbuchner (AT)

Basic/Translational Science/Genetics Dr. Carlo Napolitano (IT)Prof. Joachim Ehrlich (DE) Dr. David Arnar (IS)

Cardiostim RepresentativesDr. David Hayes (USA) Prof. Win Shen (USA) Dr. Pierre Bordachar (FR) Dr. Frederic Sacher (FR) Prof. Vincent Probst (FR) Prof. Mark O’Neill (GB)

Dr. Christine Alonso (FR)

Dr. Hubet Cochet (FR)

Prof. Didier Klug (FR)

Dr. Elad Anter (USA)

Dr. Etienne Pruvot (CH)

Prof. Frederic Anseleme (FR)

Prof. Prashanthan Sanders (AUS)

Prof. Jagmeet Singh (USA)

Prof. David Wilber (USA)

Cardiovascular Implantable Electronic DevicesDr. Michele Brignole (IT)

Prof. Jean Claude Deharo (FR)

Dr. Francis Murgatroyd (GB)

Ass. Prof. Moti Haim (IL)

Catheter Ablation Prof. Christian Wolpert (DE)

Ass. Prof. Martin Martinek (AT)

Prof. Harry Crijns (NL)

Dr. Luigi DiBiase (IT)

Clinical EP Prof. Sami Viskin (IL) Dr. Laurent Pison (NL) Prof. Richard Schilling (GB) Prof. Isabel Deisenhofer (DE) E-cardiology WG rep - Prof. Goran Krstacic (HR)

Heart Failure Prof. Giuseppe Boriani (IT) Ass. Prof. Carsten Israel (DE) Dr. Giuseppe Stabile (IT) Dr. Eyal Nof (IL)

InnovationProf. Frits Prinzen (NL)

Lead and Device Management SummitDr. Maria Grazia Bongiorni (IT)

Pediatric / Adult Congenital Heart Disease Prof. Jan Janousek (CZ) Dr. Joachim Hebe (DE) Dr. Nico Blom (ML) GUCH WG rep - G. Diller (DE)

Regulatory /Health Politics / EducationDr. Francisco Leyva (GB) Prof. Giovanni Fattore (IT) Prof. Paulus Kirchhof (GB) Dr. Angel Moya (SP)

Scientific documentsProf. Gregory Y. H. Lip (GB)

VT/VF SummitProf. Antonio Beruezzo (SP)

Women in EPProf. Andrea Sarkozy (BE)

Young EPAssist. Prof. Valentina Kutyifa (USA)

Prof. Michael Glikson (IS)EHRA Scientific Programme Chairperson

Prof. Helmut Puererfellner (AT)EHRA Scientific Programme Vice-Chairperson

Dr. Arnaud Lazarus (FR)Cardiostim Scientific Programme Chairperson

Prof. Pierre Jais (FR)Cardiostim Scientific Programme Vice-Chairperson

Dr. Philippe Ritter (FR)Cardiostim Past President

4 5

EHRA EUROPACE - CARDIOSTIM 2017 YOUR MUST-ATTEND EVENT!

The Congress Programme Committee has selected the best presentations among a broad topic list submitted.

The programme will feature new research discoveries:• Four Summits included in the registration fee: VT, AF, Lead Management and

eHealth Summit.• Access cath labs through LIVE Sessions.• Get updated with the Late Breaking Trial Session.

This year, we anticipate a record number of abstract submissions: Get updated on the latest researches by attending our various abstract sessions.

Target audience:

Electrophysiologists, Cardiologists, Basic scientists, Cardiac nurses, Intensivists, Anaesthesiologists, Internists, General physicians, Epidemiologists, Industry affiliates, Cardiac physiologists, Physicians-in-training, Medical students, Cardiac technicians…

Key figures :

4 Days of scientific exchange 5 720+ Healthcare professionals450+ International expert faculty members1 500+ Abstracts and clinical cases submitted

140+ Scientific sessions2000 m2+ Exhibition showcase 20+ Industry sponsored sessions

Meet Worldwide Renowed Experts A top quality scientific programme

Prof. Josep Brugada Terradellas (Barcelona, ES)

Prof. Charles Antzelevitch (Wynnewood, US)

Prof. Angelo Auricchio (Lugano, CH)

Prof. Pedro Brugada Terradellas (Brussels, BE)

Dr. Hugh Calkins(Baltimore, US)

Dr. Michael R Gold (Charleston, US)

Prof. Hein Heidbuchel (Edegem, BE)

Prof. Pierre Jais (Bordeaux, FR)

Dr. Andrea Natale (Austin, US)

Prof. Josef Penninger(Vienna, AT)

Prof. Sami Viskin(Tel Aviv, IL)

Dr. Stanley Nattel (Montreal, CA)

Dr. Michele Brignole (Lavagna, IT)

Prof. Paulus Kirchhof (Birmingham, GB)

Dr. Douglas L Packer (Rochester, US)

Prof. John Camm (London, GB)

Dr. Vivek Reddy (New York, US)

Dr. Francis Marchlinski (Philadelphia, US)

Dr. Paolo Della Bella (Milan, IT)

Prof. Lior Gepstein (Haifa, IL)

p

p

p

WG

p

p

p

p

Y/W

Y/W

Y/W

Y/W

ICD/C

RT

ICD/C

RT

ICD/C

RT

ICD/C

RT

EP VTAFI

BLE

AD

LEAD

NAP

NAP

NAP

NAP

NAP

NAP

NAP

LEAD

LEAD

P&S

P&S

P&S

P&S

AFIB

AFIB

AFIB

CL

CL

CL

CL

VT

VT

VT

ABL

ABL

ABL

ABL

EP

EP

EP

EP

EP

EP

EP

SS

SS

ICD/C

RTG W

G

WG

P/P

P/P

P/P

E-H

E-H

E-H

AiA

WG

WG

WG

G

G

G

6 7

Sund

ay 1

8 Ju

ne 2

017

Mon

day

19 Ju

ne 2

017

SOKOLOV SENNING WENCKEBACH MOBITZ MIROWSKI FURMAN COUMEL HIS DAMATO ELMQUIST

08:3010:00

Atrial fibrillation ablation: what do registries tell us ?

The 12 lead ECG as a daily, indispensable,

companion - Part 1

Recent advances in VT ablation: any

effect on outcome?

Atrial fibrillation, individual patients, individual therapies

Effective and safe lead extraction: meet the

experts

Gender issues in ICD and CRT therapy

Inherited arrhyt-mogenic diseases:

genetics, risk stratification and sudden cardiac death

Regulation of cardiac ion channels

10:0011:00 Coffee Break Coffee Break

11:0012:30

Predicting ICD therapies in the real

word

Cardiac devices: insights from

registries

The 12 lead ECG as a daily, indispensable,

companion - Part 2

VT-Ablation: how to deal with difficult

subststrates

New technologies in catheter ablation of atrial fibrillation:

toy or tool?

How to get it done safely: lead extraction

cases

This house believes that health care workers

should sub-specialise in either EP or Device

management’

The multiple facets of arrythmogenic ventricular

cardiomyopathy

Intracellular ion homeostasis in the heart

Single ventricle and transposition of great

arteries: challenges for the electrophysiologist

12:4513:45 LUNCH BREAK / SATELLITE SYMPOSIA LUNCH BREAK / SATELLITE SYMPOSIA

14:0015:30

Indications for ICDs in 2017

Innovative cardiac devices: do registries

help innovation ?

Interactive ECG interpretation of

tachycardias

Treatment of electrical storm: how to improve outcome

How to prevent and handle complications in catheter ablation of atrial fibrillation

The nightmare of devices infections: best

strategies

Local Language Track Developing knowledge in Austrian Nurses and

AHPs PART I

Gene and molecular therapies for cardiac arrhythmias and SCD

Repaired tetralogy of Fallot - An evidence based approach to arrhythmias


16:3018:00 Honorary Lecture

Focal atrial tachycardia: how to find the “hot spot”

How to avoid complication in VT

ablation?

The best strategy for ablation of persistent atrial fibrillation: who makes the race?

CIEDs and Lead technology: failures and

fears

Local Language Track Developing knowledge

in Austrian Nurses and AHPs PART II

Genetic discoveries to improve arrhythmia

treatment

Ion channel trafficking in the heart

Antibradycardia pacing in children

18:1519:15 INAUGURAL SESSION


08:3010:00

Late Breaking Trial Session

Best research by young

electrophysiologists

Atrial flutter: more than one of a kind

How to ablate PVCs: From the RVOT to the aortic cusp and beyond

Sinus rhythm is better than atrial fibrillation: the “rate vs.

rhythm” studies revisited in the era of ablation

CIED infections: emerging issues, diagnostic and therapeutic modalities

Arrhythmias and heart failure

Translation of cardiac cellular electrophysiology

Screening for atrial fibrillation and device detected subclinical atrial tachyarrhythmias: EHRA

position document

Remote monitoring of implantable devices:

disease management or just device management?


11:0012:30

Strong statements and controversities in EP

Young meets experienced – A case based session by the

EHRA Young EP

AV-nodal-re-entrant tachycardia: effective and safe modification AV-nodal conduction

Antiarrhythmic therapy in patients on

ventricular assist devices

Controversities in ablation therapy: asymptomatic atrial fibrillation and atrial

fibrillation in heart failure

Carmeliet-Coraboeuf-Weidmann lecture

Management of patients with atrial

fibrillation: role of nurses and AHPs

Alternative pacing sites to prevent heart failure

Antithrombotic therapy in valvular atrial

fibrillation: joint position document from EHRA and

WG thrombosis

The power of electronic health

records and computational technologies

12:4513:45 LUNCH BREAK / SATELLITE SYMPOSIA LUNCH BREAK / SATELLITE SYMPOSIA

14:0015:30

ICD therapy in inherited cardiac

disorders: indications and identification of

the best system for the appropriate patient

The future is just ahead: young

electrophysiologist initiatives of the world

WPW Syndromes revisited: from the ECG

to AP-potentials

Innovative implants for heart failure patients

Subclinical atrial fibrillation: how much is

too much?

Pacing indications - State of the art 2016

Allied health professional role

development in arrhythmia diagnosis and management

Scientific documents from EHRA

The role of the ever growing amount of data: smart data will

improve the quality of care


16:3018:00

Learning from the expert: CRT

implantation techniques

Practical approaches in the catheter ablation of complex arrhythmias

The ECG and the risk

of sudden death

Newer devices: coming soon in

the arena of clinical practice?

New strategies for prediction, prevention and treatment of atrial

fibrillation

Conduction and pacing induced cardiomyopathy

Tips for service development presentations and

publishing results - Potential abstract development

Novel avenues for cardiac cellular electrophysiology

Atrial fibrillation ablation update, joint document with HRS

The asymptomatic athlete with abnormal

EGC: all sports forbidden?

SS ICD/CRT P EP VT AFIB LEAD NAP G WG P/P

Special Session ICD and CRT Documents registries and policy

EP Educational Track VT SUMMIT AFIB SUMMIT LEAD SUMMIT Nurses / Allied Professionals

Genetics 41st Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology

Paediatric / Pregnancy

SS ICD/CRT Y/W EP ABL CL P&S NAP WG P E-H AiA

Special Session ICD and CRT Young electrophysiologist / Women in electrophysiology

EP Educational Track Ablation Clinical Pacing and syncope Nurses / Allied Professionals

41st Meeting of the ESC Working Group on Cardiac Cellular Electrophysiology

Documents registries and policy

e-health SUMMIT Arrhythmias in athletes

SS

ICD/C

RT

ICD/C

RT

ICD/C

RT

ICD/C

RT

SS

SS

SS

SS

EP

EP

EP

EP

EP AF IT

IT

IT

IT

IT

AF

AF

AFP&

S

P&S

P&S

P&S

P&S

CLEC

G

ECG

ECG

ECG

ECG

ABL

ECG

BE

BE

BE

ECG

CL

CL

CL

CL

p

p p

8 9


08:3010:00

How to improve the benefits of CRT?

LIVE SESSION I : Focus on AF ablation

SVT ablation: from the rare to the difficult:

a case based tutorial

Left atrial appendage occlusion: state of the art 2017

Innovations for better patient care:

reports from the EHRA Innovation Forum

Device programming for pacing in special

scenarios and populations

Anticoagulation for non-valvular atrial

fibrillation in 2017

New technologies for prolonged

ECG monitoring: how, when and for whom?

Medical treatment of channelopathies: effective and safe?

Hypertrophic cardiomyopathy genetics

and clinical management


11:0012:30

Strenous fights on CRT

LIVE SESSION II : MRI interventional

suites and MRI-guided ablation

Ablation of atrial macroreentrant

tachycardia: tips and tricks

Approach to atrial fibrillation

patients: highlights from Central-Eastern Europe

Crash course for inventors

Leadless Pacemaker: the future of

cardiac pacing?

State of the art on anticoagulation

12-lead ECG: diagnostic and prognostic value

Pharmacological therapy in AF

Back to nature? The rise of biologicals

to replace catheters, drugs and devices in

antiarrhythmic therapy12:4513:45 LUNCH BREAK / SATELLITE SYMPOSIA LUNCH BREAK / SATELLITE SYMPOSIA

14:0015:30

CRT implants: nightmares in the lab

LIVE SESSION III : Focus on VT ablation

EP fundamentals: what everyone should know

Hybrid ablation in persistent atrial

fibrillation: the ultimate heart team approach

Finals of EHRA inventors award and Cardiostim innovators

award

CIEDs after cardiac procedures

Stroke and bleeding in atrial fibrillation:

difficult management issues

Electrocardiogram, Holter recordings

and remote monitoring for preventing malignant ventricular arrhythmias

Is it worth the money? Cost-effectiveness in

electrophysiology

Late sodium current and cardiac arrhythmias: a basic and translational

update


16:3018:00

CRT: widening of the QRS or widening

of the indications?

Practical management approaches of

female patients with challenging arrhythmias

Burning issues in catheter ablation

in 2017

Controversies in Afib ablation Innovation Parade Syncope management:

now and futureCancer therapy and

arrhythmias

Arrhythmic substrate characterisation in the

ventricles

Improving efficacy in the EP lab: work flow, process optimisation and

economical balance

Data and evidence in ICD and CRT patients:

what´s the value?

Tues

day

20 Ju

ne 2

017

Wed

nesd

ay 2

1 Ju

ne 2

017

Y/W


08:3010:00

Keep cool: expert approaches for atrial fibrillation

cryo ablation

What´s the future of ICD therapy

Falling down: Asystolic syncope

Athlete with abnormal ECG: the

experts’ approach in 2017

Cost effectiveness of device telemonitoring

is it worth it ?

New frontiers and indications for catheter

ablation


11:0012:30

EHRA EUROPACE -

CARDIOSTIM 2017 Highlights

12:4513:45 Closing Ceremony

EP IT P&S CL ECG ABL

EP Educational Track Innovation track Pacing and syncope Clinical ECG and e-cardiology Ablation

SS ICD/CRT Y/W EP AF IT P&S CL ECG P BE

Special Session ICD and CRT Young electrophysiologist / Women in electrophysiology

EP Educational Track Atrial Fibrillation Innovation track Pacing and syncope Clinical ECG and e-cardiology Documents registries and policy

Basic Electrophysiology

10 11

Registration fees

STANDARDBASIC SCIENTIST NON-CLINICAL

(BORN AFTER 1981)***

NURSE & ALLIED PROFESSIONALS***

Non members

EHRA members

Non members

EHRA members

Non members

EHRA membersDEADLINE

ON

LIN

E

Early fee - 17 April 2017 €780 €600 €390 €310 €310 €250

Late fee - 18 May 2017 €850 €650 €430 €340 €330 €280

Last minute - 12 June 2017 €970 €750 €485 €400 €370 €300

SPECIAL RATES

• ESC Working Group on Cardiac Cellular Electrophysiology, e-Cardiology, Grown-up Congenital Heart Disease Members**: standard registation at €320

• Nurse: day ticket at €100

Day Tickets

Sunday, Monday and Tuesday €480 Wednesday (morning only) €360

The registration fees include 20% Austrian VAT. Please read the General Conditions.

* The EHRA member fees are reserved for members of the European Heart Rhythm Association (EHRA) for 2017. The 2017 EHRA Membership renewal will open mid November. Find out more about all the benefits of the EHRA membership on the EHRA Web Site.** The ESC Working Groups member fees are reserved for members of the ESC Working Groups on Cardiac Cellular Electrophysiology - e-Cardiology and Grown-up Congenital Heart Disease with membership validated before 15 October 2016 (Midnight GMT+1)*** Reduced fees:- Nurses, Allied Professionals and Basic Scientists non-clinician: a statement on official letterhead proving your status, both signed and stamped by your Head of Department, must be uploaded during the registration process.- Born after 01.01.1981: please provide a copy of your identity card or passport.

If you are contacted by any other company or agency offering housing for this congress, please note that these companies are not authorised to represent the ESC in any way, nor do they have access to the officially contracted ESC room blocks or rates. Please be aware that unauthorised companies might not deliver what they promise in terms of quality and location. Rates and extra charges can be inflated or hefty fees placed on credit cards. If you are contacted by any such agency or have any questions regarding their legitimacy please don’t hesitate to contact us at [email protected] or by telephone +33 492947623

Book your hotel

The ESC has appointed Mondial GmbH in Vienna as its official housing agency for hotel reservations for EHRA EUROPACE-CARDIOSTIM 2017.

Mondial has selected a number of hotels with negotiated rates either close to the congress centre or in the city centre with easy access.

BOOK NOW

You will be transferred to the online booking system of Mondial. Telephone requests cannot be accepted. For group reservation requests please contact Mondial directly by email:[email protected]

Best booking flexibility at an attractive discount

REGISTER NOW

https://www.escardio.org/Congresses-&-Events/EHRA-Europace-Cardiostim/travel-hotel-city/Hotels

https://www.escardio.org/Congresses-&-Events/EHRA-Europace-Cardiostim/Registration

13

Sunday 18 June 2017

12

NEWS

EHRA EUROPACE - CARDIOSTIM 2017 Mobile App is supported by Medtronic in the form of an unrestricted educational grant.

Download the EHRA 2017 Mobile App

CREATE your personnal

programme

ACCESS map, speakers...

SEARCH by key words

VOTE and ask questions

Search for 'EHRA 2017' in App Store® / Google play

www.escardio.org/EUROPACE

For more information, check the most up to date programme on:

Scientific Programme & Planner: www.escardio.org/EUROPACE

The ‘EHRA 2017’ Mobile Appavailable on App Store ® / Google play

Sunday 18 June 2017SCIENTIFIC PROGRAMME

14 15

Sunday 18 June 2017 Sunday 18 June 2017

VT AND VF SUMMIT, ATRIAL FIBRILLATION SUMMIT, LEAD AND DEVICE MANAGEMENT SUMMIT

EDUCATIONAL TRACK

LOCAL LANGUAGE TRACK

41ST MEETING OF THE ESC WORKING GROUP ON CARDIAC CELLULAR ELECTROPHYSIOLOGY

8:30 - 10:00 MAIN SESSION SENNING

Atrial fibrillation ablation: what do registries tell us ?

• EORPregistry:whatdeterminesagoodoutcomefromatrialfibrillationablationinthe‘realworld’.• EuropeanAtrialFibrillationAblationRegistry:dooutcomesinthereal-worldcomparewithtrials?• Epicardial/hybridatrialfibrillationablationregistry(EHAFAR):howdoesahybridapproachcomparetoa

transcatheterapproach?• Practiceinperspective:canregistrydataguidefuturedevelopmentsinatrialfibrillationablation?

08:30 - 10:00 MEET THE EXPERTS WENCKEBACH

The 12 lead ECG as a daily, indispensable, companion - Part 1

Educational Track

08:30 - 10:00 MAIN SESSION MOBITZ

Recent advances in VT ablation: any effect on outcome?

Joint Session with the Sociedad Brasileira de Arritmias Cardiacas VT and VF Summit

• ImageintegrationforimprovementofsuccessofVTablation.• Pace-mappingguidedVTablation.• Endo-/-epicardialablationforischemicdiseases.• Endo-/-epicardialablationinnon-ischemicdiseases.

8:30 - 10:00 SYMPOSIUM MIROWSKI

Atrial fibrillation, individual patients, individual therapies

Atrial Fibrillation Summit

• Atrialfibrillationinthechannelopathies.• Atrialfibrillationinhypertrophiccardiomyopathy.• Atrialfibrillationandheartfailure.• Atrialfibrillation:valueofpersonalisedtherapyandintegratedcare.

8:30 - 10:00 MEET THE EXPERTS FURMAN

Effective and safe lead extraction: meet the experts

Lead and Device Management Summit

• Poweredornon-poweredleadextraction:doesitmakeadifference?• HowdoIproceedwithleadextractionwhenastyletcannotbeintroduced?• WhendoIproposeelectivesurgicalleadextractionprocedure?

8:30 - 10:00 SYMPOSIUM COUMEL

Gender issues in ICD and CRT therapy

• Electrophysiologicdifferencesbygender.• Differentialsusceptibilitytoventriculararrhythmiasbygender:clinicaldata.• DifferentialeffectsofICDandCRTinWomen.• Whywomendon’tgetit?

8:30 - 10:00 MAIN SESSION HIS

Inherited arrhythmogenic diseases: genetics, risk stratification and sudden cardiac death

• HowtointerpretLabresultsingeneticarrhythmiascounseling?• Novelriskstratificationtoolsforinheritedarrhythmias.• Whatisnewinearlyrepolarisation?• GeneticsofSCDandidiopathicVF:theclinicalvalueofmolecularautopsyandfamilyscreening.

08:30 - 10:00 FEATURED SYMPOSIUM DAMATO

Regulation of cardiac ion channels


11:00 - 12:30 SYMPOSIUM SOKOLOV

Predicting ICD therapies in the real word

• NewdataontheincidenceandpreditorsofICDtherapyandsurvival-LessonfromtheIsraeliICDregistry.• Theroleofimaginginriskstratification.• Autonomicmarkersofarrhythmicrisk.• Riskstratificationandmortalityin2016:implicationsforICDimplantation?

11:00 - 12:30 MAIN SESSION SENNING

Cardiac devices: insights from registries

• Co-morbidity and outcomes from device therapy: Insights from the Registry of Emilia Romagna onArrhythmiaInterventions(RERAI).

• Doesgenderinfluencetheoutcomeofdeviceorareclinicalcharacteristicsdifferentinwomen? TheMulticentreFrenchRegistry.

• Ispracticeindevicetherapychanging?Thepacemakerimplantablecardioverter-defibrillatorRegistryoftheItalianAssociationofArrhythmologyandCardiacPacing(AIAC).

• Areheartfailurepatientsreceivingguideline-indicateddevicetherapy:theeuropeanheartfailureregistry.

DO

N’T

MIS

S

16 17


11:00 - 12:30 MEET THE EXPERTS WENCKEBACH

The 12 lead ECG as a daily, indispensable, companion - Part 2

Educational Track

11:00 - 12:30 SYMPOSIUM MOBITZ

VT-Ablation: how to deal with difficult subststrates

VT and VF Summit

• Ablationofpapillarymuscletachycardia.• AblationinsarcoidosisandARVC:theneedfortheepicardialapproach.• AblationoftriggerPVCinidiopathicVFandinpostAMI.• SeptalVTablation.


New technologies in catheter ablation of atrial fibrillation: toy or tool?

Atrial Fibrillation Summit• Theimpactofcontactforceonprocedureoutcome.• Rotorablation:anyprovenindication?• Ablationofautonomicganglia:hopeorhype?• Highdensitymapping:toyortool?

11:00 - 12:30 SYMPOSIUM FURMAN

How to get it done safely: lead extraction cases

Lead and Device Management Summit• Predictingleadextractionperi-proceduralcomplications?• Optimalpreparationofthepatientwhenleadextractionisplanned.• Optimalpreparationofalead-extractingcenter.• Oneyearafterleadextraction:lessonsfromtheELECTRaRegistry.

11:00 - 12:30 DEBATE SESSION COUMEL

This house believes that health care workers should sub-specialise in either EP or Device management’

• Initialvotefromtheaudienceandchairperson.• Healthcareworkersshouldsub-specialiseineitherEPorDevicemanagement:thecaseFORsub-specialism-PRO.•Healthcareworkersshouldsub-specialiseineitherEPorDevicemanagement:thecaseAGAINST

sub-specialism-CONTRA.• Healthcareworkersshouldsub-specialiseineitherEPorDevicemanagement-RebuttlePRO.• Healthcareworkersshouldsub-specialiseineitherEPorDevicemanagement-rebuttalCONTRA.• QuestionsandAnswers.• Finalvotefromtheaudience.

11:00 - 12:30 SYMPOSIUM HIS

The multiple facets of arrythmogenic ventricular cardiomyopathy

• Theroleofgeneticsforprobandspatientsandfamilymembers.• MolecularpathogenesisofARVC.• What´sneededfordiagnosisandriskstratification?• Currenttherapeuticconcepts-Asummaryofthe2015internationaltaskforceconsensusstatement.


Intracellular ion homeostasis in the heart


11:00 - 12:30 MAIN SESSION ELMQUIST

Single ventricle and transposition of great arteries: challenges for the electrophysiologist

• Post-surgicalanatomy.• Arrhythmiasandcatheterablationinsingleventriclepatients.• ArrhythmiasandcatheterablationinTGApatients.• Roleofsurgicalablationandimplantationtechniquesforcardiacresynchonisationtherapy.

14:00 - 15:30 DEBATE SESSION SOKOLOV

Indications for ICDs in 2017

• AfterDANISH:primarypreventionofSCDwiththeICDinNICMisdead!• AfterDANISH:primarypreventionofSCDwiththeICDinNICMisstillalive!• SCICDformostpatientswithoutpacingindication-PRO.• SCICDformostpatientswithoutpacingindication-CONTRA.

14:00 - 15:30 SYMPOSIUM SENNING

Innovative cardiac devices: do registries help Innovation ?

• HowdoestheS-ICDcomparewithatransvenousICD?-TheEFFORTLESSregistry.• TheMICRAregistry:primetimefortheleadlesspacemaker?• HowdoesaregistryinfluenceInnovation?-TheKaiserPermanente-CardiacDeviceRegistry.• AreregistriesforregulationorforInnovation?

14:00 - 15:30 SYMPOSIUM WENCKEBACH

Interactive ECG interpretation of tachycardias

Educational Track

ECGdiscussionandinteractionwiththeaudience

• ECG1.SupraventriculartachycardianarrowQRScomplex.• ECG2.Ventriculartachycardia.• ECG3.TachycardiawithwideQRScomplex.

18 19



Treatment of electrical storm: how to improve outcome

VT and VF Summit

• Electricalstorm:whatisthebesttimingforintervention?• Ablationstrategyineletricalstorm.• Drugsorablation:Isthereadifferenceinrecurrencerateandsurvival?• Failedablation:whatisnext?


How to prevent and handle complications in catheter ablation of atrial fibrillation


• Introduction:themostimportantcomplicationsofcatheterablation.• Tamponade:recognitionandtreatment.• Phrenicnervepalsy:howtoavoid?• PVstenosis:stillanissue!• Atrialesophagealfistula:preventionandtreatment.


The nightmare of devices infections: best strategies


• Isitanearlypocketinfection?incisionalinfection?Earlypostimplantationinflammation?• Whattodowithcontra-lateralleadsincaseofipsi-lateralinfection?• Howdoyou“bridge”yourpatientsbeforereimplantation?• Reimplantationepicardial?endocardial?subcutaneous?leadless?


Developing knowledge in Austrian Nurses and AHPs PART I. German speaking stream for local nurses and AHPs

Local language session - Presentation will be given in German with slides in English.

• Transseptalpuncture,what’sthenursesrole:complicationsthatcanarise. Transseptalpunktion,dierollederkrankenschwester:komplikationendasauftretenkann.

• EPU:whatareallthoselinesonthemonitor?Makingsenseofwhat,whereandhowtolookandinterpret. EPU:wassindalledieseLinienaufdemMonitor?Sinnvollvondem,was,woundwiesieaussehen

• Mappingsystemsforbeginners:tipsandtricksforbestresults. Mapping-systemefüranfänger:tippsundtricksfürdiebestenergebnisse.

• Telemonitoring:nurse-ledtelemonitoring. Telemonitoring:krankenschwestergeführtentelemonitoring.


Gene and molecular therapies for cardiac arrhythmias and SCD

• Genetherapycalciumhandlingdysfunctioninheartfailure.• Genetherapyofinheritedarrhythmias.• MolecularstrategiestotreatpostMIarrhythmias.• Genetherapy:thefutureofpersonalisedatrialfibrillationmanagement?


Repaired tetralogy of Fallot - an evidence based approach to arrhythmias

• Post-surgicalanatomy.• Catheterandsurgicalablationstrategies.• Preventionofsuddencardiacdeath.• Pacingapproachtorightheartfailure.

16:30 - 18:00 SPECIAL SESSION SENNING

Honorary Lecture

• Intercontinentallecture.AtrialFibrillation:whatwentwrong?Whatwentright?Whatdoweneedtodonext?.• EinthovenLecture:50yearsofclinicalelectrophysiology.

16:30 - 18:00 HOW-TO SESSION WENCKEBACH

Focal atrial tachycardia: how to find the “hot spot”

Educational Track

• LessonsfromthesurfaceECGandbodysurfacemapping.• Conventionalfluoroscopically-guidedmappingandpacemappingoffocalatrialtachycardia.• 3-Dnon-fluoroscopicmappingandablationoffocalatrialtachycardia.• Multifocalatrialtachycardia.


How to avoid complication in VT ablation?

VT and VF Summit

• Accesssite,materialandtechniqueforepicardialpuncture• Howtoavoidembolism,phrenicpalsyanderosionofthecoronaryarteries.• Whentouseretrograde,antegrade,epicardialorroboticinVTablation?• Managementofcomplications:whatdoweallneedtoknow?


The best strategy for ablation of persistent atrial fibrillation: who makes the race?


• SolidPVIonlyisstillenough.• Mappinginsinusrhythm:substratemodificationmakesthedifference.• MappingAFinAF:rotorsandterminationstrategies.• NonPVtriggerablationandLAAisolation.

20 21



CIEDs and Lead technology: failures and fears


• SprintFidelisleadadvisory:nearly10years.• Riataleads:6yearsaftertheadvisory.• Batterieissues:howtohandle?• Quadripolarleftventricularpacingleads:safetechnology?


Developing knowledge in Austrian Nurses and AHPs PART II. German speaking stream for local nurses and AHPs

Local language session - Presentation will be given in German with slides in English.

• UpdateCPRguidelines,areweretrainingoftenenough? AktualisiertCPR-richtlinienwerdenumschulungoftgenug?

• Suddencardiacdeathinsports«helppeoplelearnhowtheycansavelives”. Plötzlichenherztodimsport„Menschenhelfenzulernen,wiesieLebenrettenkönnen“!

• Defibrillators,AEDs,lifevestsandICDs“notallshocksarecreatedequal”. Defibrillatoren;AED,lifevestsundICDs«nichtalleschockssindgleich”.

• 1stCIEDcontrolafterimplant:optimisedprogramming. ErsteCIEDkontrollenachderimplantation:optimierteprogrammierung.


Genetic discoveries to improve arrhythmia treatment

• Genetics,GWAS,andsuddencardiacdeath:anupdate.• AdvancedinusingIPSmodeling...• SystematicfamilyscreeningtoreducetheburdenofSCDintheyoung.• WhathavewelearnedaboutAFmechanismsfromGWAS?• WholepopulationscreeningforgeneticmutationsthatcauseinheritedarrhythmiasyndromesinIceland.

Isitrealistic(anduseful)?


Ion channel trafficking in the heart



Antibradycardia pacing in children

• Evolvingindications:whatisnew?• Pacingsystemsurvival:thingstoimprove.• Leadimplantationandextractionissues.• HemodynamicoptimisationandCRT

18:15 - 19:15 SPECIAL EVENT SOKOLOV

Inaugural Session

Followed by a Networking Reception in the exhibition

Monday 19 June 2017SCIENTIFIC PROGRAMME




22 23

Monday 19 June 2017 Monday 19 June 2017

E-HEALTH SUMMIT

EDUCATIONAL TRACK

41ST MEETING OF THE ESC WORKING GROUP ON CARDIAC CELLULAR ELECTROPHYSIOLOGY

8:30 - 10:00 SPECIAL SESSION SOKOLOV

Late Breaking Trial Session

Presentersfromaroundtheworldwillsharetheveryresultsoftheirtrials.


Best research by young electrophysiologists

InthissessionyoungEPswillpresenttheirbestpublishedresearchpapersin2016-2017


Atrial flutter: more than one of a kind

Educational Track

• UnderstandingthesurfaceECGinatrialmacro-re-entranttachycardia.• Electrophysiologicassessment,activationandentrainmentmapping.• Scarrelatedatrialmacro-re-entranttachycardiaintherightatrium.• Atrialmacro-re-entranttachycardiaafteratrialfibrillationablation.

8:30 - 10:00 HOW-TO SESSION MOBITZ

How to ablate PVCs: From the RVOT to the aortic cusp and beyond

Joint Session with the Japanese Heart Rhythm Society (JHRS)

• Localisationofthesource.• RVOTandLVOT.• Ablationatuncommonsites.• Ablationofepicardialorigine


Sinus rhythm is better than atrial fibrillation: the “rate vs. rhythm” studies revisited in the era of ablation

• Whatdothe“ratevs.rhythmcontrol”studiesreallytellus?• Ablateatrialfibrillationtoimprovequalityoflife.• AblateatrialfibrillationtoimproveCHFandpreventICDshocks.• Ablateatrialfibrillationtopreventstroke.


CIED infections: emerging issues, diagnostic and therapeutic modalities

• InfectionofsubcutaneousICD:notanissue?• Leadlesspacemakerinfection:doesitexistandhowtomanage?• Theantibioticenvelope:shallweuseitforallimplants?• PETScan:doesithelp?


Arrhythmias and heart failure

• Atrialfibrillationandheartfailure–Whichconditioncomesfirstanddoesitaffectmanagement?• Devicesinheartfailure:ethicsanddecisionmakingatdeviceimplant.• VTablationinpatientswithheartfailureandICDstorm-Whichpatientsareappropriateandshouldwe

delivera24/07service?• Let’stalkaboutdeath:endoflifemanagementinpatientswithdevices.

11:00 - 12:30 FEATURED SYMPOSIUM HIS

Translation of cardiac cellular electrophysiology


08:30 - 10:00 MAIN SESSION DAMATO

Screening for atrial fibrillation and device detected subclinical atrial tachyarrhythmias: EHRA position document

• Rationaleforscreening.• Toolsforscreening.• Screeningstrategies.• RoleoftheGP,healthcarecostsandpatientacceptance.• Whattheconsensusdocumentsays?

8:30-10:00 SPECIAL SESSION ELMQUIST

Remote monitoring of implantable devices: disease management or just device management?

e-Health SummitWith the contribution of the ESC WG e-cardiology and the EHRA Study Group e-health and digital rhythm

• OptiLink:diseasemanagementusingoptivol.• REM-HF:Isweeklymonitoringworthwhile?• TRUSTandIN-TIME:Hopeforthefuture?• Implantablemonitoring-onlytechnologies:CardioMEMSandLAPTOP.

DO

N’T

MIS

S

24 25


11:00 - 12:30 SPECIAL SESSION SOKOLOV

Strong statements and controversities in EP

• LAA-occlusiondoesnotreduceischemicstroke!• Paneldiscussion.• Remotedevicemonitoringdoesnotimproveoutcome!• Paneldiscussion.• VTablationdoesnotreducemortality!• Paneldiscussion.

11:00 - 12:30 MEET THE EXPERTS SENNING

Young meets experienced – A case based session by the EHRA Young EP

ThissessionwillencompassintriguingcasesmoderatedbyexperiencedEPs


AV-nodal-re-entrant tachycardia: effective and safe modification AV-nodal conductio

Educational Track

• UnderstandingtheAV-node:anatomy,fluoroscopicanatomyandcatheterpositions.• BasicassessmentofAV-nodalconductionpropertiesandofdifferentinputmechanismsintotheAVnode.• TargetsitesforAV-nodemodification.• CatheterablationofatypicalAVNRT.


Antiarrhythmic therapy in patients on ventricular assist devices

Joint Session with Acute Cardiovascular Care Association (ACCA)

• Acutemechanicalsupportaspartofarrhythmiamanagement.• LVADtechnologiesnowandinthefuture.• AblationinLVADpatients.• CIEDsandLVADpatient.

11:00 - 12:30 DEBATE SESSION MIROWSKI

Controversities in ablation therapy: asymptomatic atrial fibrillation and atrial fibrillation in heart failure

• Patients with paroxysmal atrial fibrillation should undergo ablation, even if asymptomatic, to preventstrokeandlife-longanticoagulation-PRO.

• Patients with paroxysmal atrial fibrillation should undergo ablation, even if asymptomatic, to preventstrokeandlife-longanticoagulation-CONTRA.

• Ablationofatrialfibrillationshouldbeusedfrequentlyinheartfailure-PRO.• Atrialfibrillationablationisrarelyneededinheartfailure-CONTRA.

11:00 - 12:30 FEATURED SYMPOSIUM FURMAN

Carmeliet-Coraboeuf-Weidmann lecture



Management of patients with atrial fibrillation: role of nurses and AHPs

• TheESC2016guidelinesonthemanagementofatrialfibrillation:what’sinitfornursesandAHPs?• Atrialfibrillationandablationtherapy:whogainsmostbenefit:theelectrophysiologistorthepatient?• Post-dischargeECGHoltermonitoringinrecentlyhospitalisedindividualswithchronicatrialfibrillationto

enhancetherapeuticmonitoringandidentifypotentiallypredictivephenotypes.• Whatdopatientswithatrialfibrillationwantfromservices?Thepatientperspective.


Alternative pacing sites to prevent heart failure

• Hisbundlepacingrationaletechniqueandresults.• RVoutflowtractandRVseptalpacing.• CRTPinbradyindications.• Howtoavoidtricuspiddamagebypacing.


Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis

• Epidemiologyofvalvularatrialfibrillationandimplicationsforstroke/thromboembolism.• Evidenceforantithrombotictherapyfromtrials.• Evidenceforantithrombotictherapyfromobservationalcohorts.• Mechanicalheartvalves,bioprostheses,TAVI.• Whattheconsensusdocumentsays.

11:00 - 12:30 SYMPOSIUM ELMQUIST

The power of electronic health records and computational technologies


• GeneticsofLongQTandelectronichealthrecords.• ComputationalpredictionofacquiredLongQTanddrug-inducedTorsadesdePointes.• Insilicoassessmentofcardiacsafetyofanti-arrhythmicdrugs• LongQTindigitalECGofgeneralpopulation:significanceandgenetics

26 27



ICD therapy in inherited cardiac disorders: indications and identification of the best system for the appropriate patient

• ICDtherapyinJWavesyndrome.• ICDtherapyinLQTS.• ICDtherapyinARVC.• ICDinathletes-Specialconsideration.


The future is just ahead: young electrophysiologist initiatives of the world

Joint Session with EHRA – HRS – SOLEACE – Brazil - APHRS

• EHRA:ourviewonAFablation. Discussion.

• HRS:ourviewonheartfailureimplants. Discussion.

• SOLEACE:ourviewonVTablation. Discussion.

• APHRS:ourviewonstrokeprevention. Discussion.

• QuestionsandAnswers.


WPW Syndromes revisited: from the ECG to AP-potentials

Educational Track

• Whereisthepathway:preciseAPlocalizationfromthesurfaceECG.• Electrophysiologicassessmentofaccessorypathwayconductionproperties.• Identificationofsuccessfulablationsites:APpotentialsandothercriteria.• Variantsofpre-excitation:thewiredandtoughstuff.


Innovative implants for heart failure patients

Mobile App - Voting session

• Spinalcordneuromodulation.• Vagalstimulationdevices.• Intracardiacshuntdevices.• LeadlesstechnologyforCRT.


Subclinical atrial fibrillation: how much is too much?

• MultipleAPCsasprecursorsofatrialfibrillation.• Howtoscreenforatrialfibrillationinhighriskpopulation.• Devicedetectedatrialfibrillation:howmuchistoomuch?• Subclinicalatrialfibrillationincryptogenicstroke.


Pacing indications - State of the art 2016

Joint Session with the Cardiac Arrhythmia Society of Southern Africa (CASSA)

• Carotidsinusandvasovagalsyncope.• Sinusnodedysfunction.• Bundlebranchblock.• ModeSelectionandtheroleofdifferentpacingminimisationalgorithms.


Allied health professional role development in arrhythmia diagnosis and management

• Nurse-ledpalpitationsdiagnosticclinics:themiddlesbroughexperience.• Remotemonitoring:gettingthebestoutofyourremoteclinics.• Novelinterventionstoimprovethearrhythmiapatientpathway:dowehaveevidenceofeffectiveness?• Postablationfollow-upandtheimportanceofriskfactormanagement:ajobforadoctororanadvanced

nursepractitioner?


Scientific documents from EHRA

• WomeninEP:radiationexposureduringpregnancy.• Managementofarrhythmiasinhypertension.• Arrhythmiasingrownupcongenitalheartdisease.• Devicedetectedsubclinicalatrialtachyarrhythmias:what’stheevidence.• Devicedetectedsubclinicalatrialtachyarrhythmias:whattheconsensusdocumentsays.

28 29


14:00 - 15:30 SPECIAL SESSION ELMQUIST

The role of the ever growing amount of data: smart data will improve the quality of car


• Dataderivedfromwearables.• Derivingclinicallyrelevantinformationfrombigdata.• Google’sdeepmindandInnovationinhealthcare.• IBM’sWatson:InnovationtoimproveInnovation.


Learning from the expert: CRT implantation techniques

• HowtoperformperipheralandcoronaryvenoplastyforLVleadimplantation.• TheuseofsnaringtechniquesinCRT.• HowtominimisefluoroscopyinCRTimplantation.• TechniquesforLVandocardialimplantation.


Practical approaches in the catheter ablation of complex arrhythmias

• Currentapproachesofpersistentatrialfibrillationablation:mypreferredapproach.• Catheterablationincongenitalheartdisease:mypreferredapproach.• Epicardialcatheterablationofventriculararrhythmias:mypreferredapproach.• Currentapproachesofischemicventriculartachycardiaablation:mypreferredapproach.


The ECG and the risk of sudden death

Educational Track

• Case1.Preexcitationsyndromes.• Case2.Abnormalrepolarizationsyndromes.• Case3.ECGinstructuralheartdiseaseandhighriskofsuddendeath.

16:30 - 18:00 MAIN SESSION MOBITZ

Newer devices: coming soon in the arena of clinical practice?

• CombinedsubcutaneousICDandleadlessVVIpacemaker:comingsoon?• LeadlessVDDpacemaker:comingsoon?• ThoracoscopicaccesstoLVepicardialpacing:comingsoon?• LeadlessLVpacing:comingsoon?• Pumonarypressuremonitoring:comingsoon?


New strategies for prediction, prevention and treatment of atrial fibrillation

Joint Session with the Asia Pacific Heart Rhythm Society (APHRS)

• Drugsforatrialfibrillationin2017:what´snew?• Lifestylechangesandsleepapnoeatreatment.• Ablationtherapyin2017–Anymajorbreakthough?• Geneticriskpredictionofatrialfibrillation.


Conduction and pacing induced cardiomyopathy

• Overtanteroseptalaccessorypathwayinducedheartfailure.• MechanismsandPathophysiologyofRVpacinginducedCMP.• PreventionofCMPby-RVseptalpacing,RVOTpacing,hisbundlepacing.• Treatment-ResultsofupgradetoCRTPorCRTD?


Tips for service development presentations and publishing results – Potential abstract development

• Identifyinganeedfordevelopment:theimportanceofdata.• Serviceevaluation:TheDundeearrhythmiaserviceexperience.• Presentingyourproject:howtochoosewhichmeetingandwhichjournaltosubmitto.• Whybother?Impactofsharingyourresultsbothonotherservicesandtopatients.

16:30 - 18:00 FEATURED SYMPOSIUM HIS

Novel avenues for cardiac cellular electrophysiology



Atrial fibrillation ablation update, joint document with HRS

• Indicationsforcatheterablation.• Strategies,techniques,andendpoints.• Proceduralaspects,anticialgulationandcomplications.• Clinicaltrialdesign.• Keytakehomemessagesandgeneraldiscussions.

30 31



The asymptomatic athlete with abnormal EGC: all sports forbidden?

Joint Session with the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

• Asymptomaticathletewithmildhypertrophiccardiomyopathy:unanimousdisqualification?• AthletewithasymptomaticARVD:anysports?• Athletewithsignificantbradycardia.• Athletewithasymptomaticventriculararrhythmias.

Tuesday 20 June 2017SCIENTIFIC PROGRAMME




32 33

Tuesday 20 June 2017 Tuesday 20 June 2017

EDUCATIONAL TRACK

INNOVATION TRACK

8:30 - 10:00 MAIN SESSION SOKOLOV

How to improve the benefits of CRT?

• ByuseofMRIforselectionofcandidates.• ByAVandVVintervalsoptimisation.• Bymultisiteormultipointpacing.• ByendocardialLVpacing.• Byextendingdevicelongevity.


LIVE SESSION I : Focus on AF ablation

• LiveCasefromLinz:ATpostAFablation.• LiveCasefromLeipzig:AFablation.• NewtechnologiesforAFablation.


SVT ablation: from the rare to the difficult: a case based tutorial

Educational Track

• AblationofPJRTandMahaim-Fibers:stillachallenge.• WhenablationofAVNRTbecomesdifficult:Thisiswhatyouneedtoknow.• Paraseptalpathways:tipsandtrickshowtoavoidAV-block.


Left atrial appendage occlusion: state of the art 2017

Learnhowexpertsapproachtheocclusionoftheleftatrialappendagetopreventstrokeinnon-valvularatrialfibrillationwithemphasisontheprosandconsofthedifferenttechnologiesavailablein2017

• Endocardialleftatrialappaendageocclusionisnotaseffectiveaswarfarintopreventischemicstroke.• Endocardialleftatrialappendageocclusionisaseffectiveaswarfarintopreventischemicstroke.• Surgicalapproachespreventingstroke.• Lariatsuturedeliverydevice:notonlyforstrokeprevention.

8:30 - 10:00 SPECIAL SESSION MIROWSKI

Innovations for better patient care: reports from the EHRA Innovation Forum

Innovation Track

• Thenearfuturepotentialofgenetics.• Thenearfuturedevelopmentsinpharmacologicaltherapies.• Thenearfutureofprecisionmedicine.• Thenearfutureapplicationsofcomputermodeling.


Device programming for pacing in special scenarios and populations

• Neuro-musculardiseases.• WhenispacingindicatedinhypertrophicCMP?• Pacingin1stdegreeAVBlock.• Pacinginpatientswithunexplainedsyncope.


Anticoagulation for non-valvular atrial fibrillation in 2017

Joint Session with the Heart Rhythm Society (HRS)

• Whatisthecorrectdefinitionof“non-valvular”atrialfibrillation?• PermanentatrialfibrillationwithCHADS-VASCscore=1:nothing,aspirinoranticoagulate?• AnticoagulantshouldbeprescribedforAtrialfibrillationinstageIV-Vkidneydisease.• AnticoagulantshouldNOTbeprescribedforAtrialfibrillationinstageIV-Vkidneydisease.


New technologies for prolonged ECG monitoring: how, when and for whom?

• Multi-dayandmulti-weekECGrecordingsystems.• ImplantableLooprecorders.• MobilephoneECGapplicationsandwearables.• NovelcharacteristicofECGmorphologyforarrhythmiaprediction.

8:30 - 10:00 SYMPOSIUM DAMATO

Medical treatment of channelopathies: effective and safe?

• QuinidineforBrugadaandwhattodowithQuinidineintolerance.• RanolazineforLQT3:Treatmentthatfoundit’sdisease?• Beta-blockersforLQT3:Contraindicated,acceptableorthedrugofchoice?• LQT3–theroleofAjmalinechallengeandofFlecainideandmexilletineintreatment.

DO

N’T

MIS

S

34 35



Hypertrophic cardiomyopathy genetics and clinical management

• DiagnosticandprognosticroleofgenotypinginHCM.• RiskstratificationofHCMin2017:theEuropeanapproach.• AtrialfibrillationandoutcomeinHCM:theAmericanapproach.• AblationinHCM.

11:00 - 12:30 DEBATE SESSION SOKOLOV

Strenous fights on CRT

• Cardiacresynchronizationtherapyinthenextyears:CRT-Pwillbethepreferreddevice.• Cardiacresynchronizationtherapyinthenextyears:CRT-Dwillbethepreferreddevice.• OnlyLBBBiseligibletoCRT.• ImprovingthecriteriaofcandidacyforCRT:WideQRSonlyforeligibilitytoCRT.


LIVE SESSION II : MRI interventional suites and MRI-guided ablation

• LiveCase:MRIinterventionalsuites:catheterablationintheMRI.• LiveCasefromLeipzig:VTablationguidedbyMRI-basedchanneldetection• Lecture:MRIapplicationsinarrhythmiapatients.


Ablation of atrial macroreentrant tachycardia: tips and tricks

Educational Track

• Whattoknowaboutatrialanatomyforatrialflutterablation.• Howtoablatescar-relatedflutteraftercardiacsurgery.• Howtoprovereentrycircuitsandablatepost-PVImacroreentrants.• Ablationofpost-Mazearrhythmias.


Approach to atrial fibrillation patients: highlights from Central-Eastern Europe

Special session of the Eastern European group

• Radiofrequencyablationwithwith3Delectroanatomicalmapping inptswithatrialfibrillation,whyandwhenisalwaysmyfirstapproach:clinicalrecommendations.

• Veinisolationbycryoballoon:howtoreadelectricalsignalsfrompulmonaryveins?• AtrialfibrillationinpatientswithICD/CRTD:therapyissuesandprogrammingrecommendations.• ICDforpreventionofSCD:lessonslearnedfromICDforlifeinitiative.


Crash course for inventors

Innovation Track

• Fromprofessortoprofessionalininventing.• Strategicalthinkingforinventors.• HowtogetyourInnovationtobetakenseriously.• Fromconcepttocertificationofanablationcatheter.• Ismyinventionworthpursuing?Abeginnersguide.

11:00 - 12:30 MAIN SESSION FURMAN

Leadless Pacemaker: the future of cardiac pacing?

• Wheredowestand:updateonclinicaltrialsandregistries.• WhoaretheidealcandidatesforcurrentLeadlessPacemakertechnology?• ImplantationTechniques:tipsandavoidingcommoncomplications.• FromVVItoDDDandCRT:what’sinthepipelineofleadlesspacing?


State of the art on anticoagulation

• Choosingtherightanticoagulantfortherightpatient.• Usinglong-termECGmonitortostartandstopanticoagulation.• Antidotestoanticoagulation:stateoftheart.• Choosingtheanticoagulantaspartoftripletherapy.


12-lead ECG: diagnostic and prognostic value

• TheECGinBrugadasyndrome:predictingVF.• TheECGinAVblock:predictingtorsadedepointes.• ShortQT:predicting(orguessing?)VF.• ECGbeforeandafterTAVI:predictingAVblock.


Pharmacological therapy in AF

• ThecurrentroleofDronedarone.• Ranolazine–mechanismandclinicalresultsinAF.• Atrial-specificantiarrhythmicagents.• Nonantiarrhythmicpharmacologicaltherapyformaintenanceofsinusrhythm.

36 37



Back to nature? The rise of biologicals to replace catheters, drugs and devices in antiarrhythmic therapy

• Thebiopacemaker-readyforapplicationinhumans?• Biologicalablationofatrialandventriculararrhythmias.• DecypheringarrhythmiamechanismsusinghumaniPSC-derivedcardiomyocytes.• Electricallyactiveantibodies:emergingrolesinpathophysiologyandantiarrhythmictherapy.


CRT implants: nightmares in the lab

• Impossiblecoronarysinuscannulationandcoronarysinusdissection:whattodo?• IndicationandtechnicalaspectsofepicardialLVImplantation.• Leftpersistentsuperiorvenacava:whattodo?• InstabilityoftheLVleadandphrenicnervestimulation:whattodo?


LIVE SESSION III: Focus on VT ablation

• LiveCasefromLinz:highdensitymappingforablationofpostMIVT.• LiveCasefromLeipzig:Epi-endocardialmappingandablationofVTinNICM.• NewtechniquesandtechnologiesforVTablation.• Discussionpanel.


EP fundamentals: what everyone should know

Educational Track

• Theworldofentrainment:amustforeveryone.• StimulationmanoeuversfordifferentiationbetweenSVTs.• StimulationmanoeuversfordifferentiationofSVTfromVT.• Differentialpacingandothermodestoproveconductionblock:howdoesistwork?


Hybrid ablation in persistent atrial fibrillation: the ultimate heart team approach

Joint Session with Chinese Society of EP

• Pathophysiologicalaspectsofpersistentatrialfibrillationrelevanttoablation.• Evolutionofsurgicalablationofatrialfibrillation.• RationaleforahybridsurgicalandcatheterablationapproachforpersistentAF.• Long-termoutcomeinhybridablationofatrialfibrillation.


Finals of EHRA inventors award and Cardiostim innovators award

Innovation Track

• EHRAInventorAwardandCardiostimInnovationAwardfinalists• Thelongandwindingroadofaninvention:theLINQ-revealstory.• PresentationofEHRAinventorsaward.• PresentationofcardiostimInnovationaward.• Referees-Paneldiscussion.


CIEDs after cardiac procedures

Joint session with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

• Predictorsandtimingofpacemakerimplantationaftersurgicalvalvularprocedures.• CIEDSfollowingtricuspidsurgicalprocedures.• PacingafterTAVI:theinterventionalviewpoint.• PacingafterTAVR:theelectrophysiologistviewpoint.


Stroke and bleeding in atrial fibrillation: difficult management issues

• AcutebleedinginanAFpatientonNOAC:howtousereversalagentsappropriately?• Anticoagulationaftercatheterablation:isstopinganticoagulationreallyagoodideainCADsVASc>2?• AcuteischaemicstrokeinAFpatientonaNOAC:Thrombolysis,thrombectomyorpray?Andwhattodonext?• HighCHADsVAScandNOAF:anyindicationforanticoagulation?

14:00 - 15:30 HOW-TO SESSION HIS

Electrocardiogram, Holter recordings and remote monitoring for preventing malignant ventricular arrhythmias

• HowtodetectandpreventdruginducedlongQTsyndrome.• HowtodetectandpreventdruginducedBrugadasyndrome.• HowtoperformaQTstudyfornewdrugs.


Is it worth the money? Cost-effectiveness in electrophysiology

• Comparativecost-effectivenessofatrialfibrillationablationversuspharmacologicaltherapy.• Patientcomplianceandoutcomesofpharmacologicaltherapyandatrialfibrillationablation.• CommissioningandreimbursementofatrialfibrillationablationinEurope.• TheroleoftheESCHealthPolicy:relevancetoelectrophysiologyandcardiacdevicepractice.

38 39



Late sodium current and cardiac arrhythmias: a basic and translational update

• Molecularandbiophysicalmechanismsunderlyinglatesodiumcurrent.• Latesodiumcurrentandatrialfibrillation.• Latesodiumcurrentandarrhythmogenesisduringheartfailure.• PharmacologicallateINainhibitionininheritedarrhythmias.


CRT: widening of the QRS or widening of the indications?

Joint Session with the Heart Failure Association of the ESC (HFA)

• CRTinNYHAIV:never?sometimes?• CRTinpatientswithvalvularheartdisease:when?whatresults?• CRTindiastolicdysfunction:never?sometimes?• CRTinspecialsituationNYHAI/atfirstdetectionofheartfailure.


Practical management approaches of female patients with challenging arrhythmias

Mobile App - Voting session

• MypracticalapproachtotreatmentoffemalepatientswithBrugadasyndrome.• Mypracticalapproachtocatheterablationofatrialfibrillationinfemalepatients.• MypracticalapproachofPM/ICDimplantationinfemalepatients.• Mypracticalapproachofleadextractioninfemalepatients.


Burning issues in catheter ablation in 2017

Educational Track

• Howtoreduceoreliminateradiationexposure.• Cryoablationorradiofrequency:WhatisbestforAVNRTandparaseptalpathways?• Ablationofasymptomaticaccessorypathways:isitreallynecessary?• IsthereanyrolefortypicalisthmusflutterablationwithoutPVI?

16:30 - 18:00 DEBATE SESSION MOBITZ

Controversies in Afib ablation

• Cryoablationshouldbefirstchoiceinpersistentatrialfibrillation-PRO.• Cryoablationshouldbefirstchoiceinpersistentatrialfibrillation-CONTRA.• NOACsshouldnotbeinterruptedforAfibablation-PRO.• NOACsshouldnotbeinterruptedforAfibablation-CONTRA.


Innovation Parade

Innovation Track

16:30 - 18:00 MAIN SESSION FURMAN

Syncope management: now and future

• Recurrentvasovagalsyncope:pacemakerrevisited.• Whoshouldbeadmittedtohospital:riskstratificationandsyncopemanagementunit.• Recentadvancesinambulatoryhemodynamicandrhythmmonitoring.• Syncope:whoisfittodrive?


Cancer therapy and arrhythmias

• HighlightsofESCpositionpaperoncardio-oncology.• ArrhythmiasinducedbyChemotherapyandbiologicaltreatment.• Radiotherapyandtheheart.• Anticoagulationinpatientswithblooddyscrasiasandadvancedcancer.


Arrhythmic substrate characterisation in the ventricles

Joint Session with the European Association of Cardiovascular Imaging (EACVI)

• Non-invasiveelectrocardiographicimagingforarrhythmicsubstratemapping.• Myocardialdeformationimagingforarrhythmicsubstratemapping.• Simulation-based differentiation between electrical and structural substrates of arrhythmogenic right

ventricularcardiomyopathy.• Exercise-induceddamagetotherightventricle:theroleofMRI.

40 41



Improving efficacy in the EP lab: work flow, process optimisation and economical balance

• Thevalueofimprovedworkflow:processoptimizationmedicine.• UnderstandingeconomicsinEP:benchmarks,costsandreimbursement.• AviewfromtheIndustry.• Costimpactandcost-effectivenessofablationanddevicetherapycomparedtoothermedicaltherapies.

16:30 - 18:00 DEBATE SESSION ELMQUIST

Data and evidence in ICD and CRT patients: what´s the value?

• SubanalysesinCRT:shouldtheybetrusted?-PRO.• SubanalysesinCRT:shouldtheybetrusted?-CONTRA.• ItistimetoreassesscurrentICDindicationsbycontrolledstudies-PRO.• ItistimetoreassesscurrentICDindicationsbycontrolledstudies-CONTRA..

Wednesday 21 June 2017SCIENTIFIC PROGRAMME




42 43

Wednesday 21 June 2017 Wednesday 21 June 2017

EDUCATIONAL TRACK

INNOVATION TRACK


Keep cool: expert approaches for atrial fibrillation cryo ablation

Educational Track, Mobile App - Voting session

• Patientselectionforatrialfibrillationcryoablation.• Proceduralaspects:howtopleacetheballoonbestindifficultanatomies?• Safetyaspects:howtoavoidcomplications.• Cryoablationinpersistentatrialfibrillation:wheredowestand?

8:30 - 10:00 HOW-TO SESSION MIROWSKI

What´s the future of ICD therapy

Innovation Track

• Newtechnologies:smallerdevices,novelimplantationstrategies,betterlongevityandlesscomplications?• ImplantableassistdeviceswillsupplementorreplacetheICD?• AblationtechnologywillsupplementorreplacetheICD?• Newindicationsforprimarypreventionatthehorizon?


Falling down: Asystolic syncope

• Seizureandasystole:thehenandeggdilema.• Pacingforictalasystole.• Asystoleinreflexsyncope.• Asystolecausedbyconductiondisturbances.


Athlete with abnormal ECG: the experts’ approach in 2017

Joint Session with the Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)

• Athletewithventriculararrhythmia.• Athletewithborderline,shortorlongQT.• AthletewithAF,SVTandWPW.• AthletewithJwavesyndromes.


Cost effectiveness of device telemonitoring is it worth it ?

• Tele-rehabilitationstrategyafteracutecoronarysyndromes. • Remotemanagementofpatientswithchronicheartfailure:nurseordevice? • Remote monitoring of pacemakers / ICDs to detect clinically important silent atrial fibrillation

episodes.• Remotediagnosisofpreviouslyundocumentedpalpitations:isitfeasible?

8:30 - 10:00 HOW-TO SESSION DAMATO

New frontiers and indications for catheter ablation

• Sinusnodemodificationinheartfailurepatients.• Ablationinorofbrugadasyndrome?• Ablationofventricularfibrillation.• Transcutaneousablationofarrhythmias.

10:05 - 10:55 SPECIAL EVENT AGORA

Awards Ceremony

Comeandsupportthefinalist!

11:00 - 12:30 SPECIAL SESSION MOBITZ

Congress Highlights

NEW THIS YEAR: Expertswillsummarisethehighlightsofthecongressbytopic.

Don’tmissthissessiontogetanoverviewofthisyear’scongress!

DO

N’T

MIS

S

44

Wednesday 21 June 2017

Up to 220 Euros savings on EHRA annual congress: EHRA EUROPACE-CARDIOSTIM 2017

Reduced fee for the EP Europace Journal

Discounted fee for EHRA educational courses

Exclusivity to EHRA Training Fellowship Programmes and Grants

EHRA monthly webinars

EHRA quarterly newsletter

ESC eLearning platform

Automatic ESC Membership

Voting rights*

JOIN EHRA

www.escardio.org/EHRA-membership

E U R O P E A N H E A R T R H Y T H M A S S O C I AT I O N

Be part of the leading network of European Cardiac Rhythm Management, connect with EHRA and access all 2017 benefits:

* reserved to members of ESC National Cardiac Societies

I‘m an EHRA member. We are the ESC

• Invasive & Non-Invasive Electrophysiology • Catheter Ablation • • Pacing and Defibrillation • Heart Failure • Cardiac Imaging • Angiogenesis & Genetics •

• Emerging Cardiovascular Technologies •

Information: Dr Philippe Ritter • CARDIOSTIM - 12, rue Pasteur F-92210 Saint-Cloud, FranceTel. +33 1 41 12 07 10 – Fax: +33 1 46 02 05 09 - E-mail: [email protected] – Web site: www.cardiostim.fr

CARDIOSTIM 200615th World Congress

in Cardiac Electrophysiology and Cardiac Techniques

June 14-17, 2006 – Nice – French Riviera

affiche ok 9/06/06 9:15 Page 1

• Invasive & Non-Invasive Electrophysiology • Catheter Ablation • • Pacing and Defibrillation • Heart Failure • Cardiac Imaging • Angiogenesis & Genetics •


Information: Dr Philippe Ritter • CARDIOSTIM - 12, rue Pasteur F-92210 Saint-Cloud, FranceTel. +33 1 41 12 07 10 – Fax: +33 1 46 02 05 09 - E-mail: [email protected] – Web site: www.cardiostim.fr



June 18-21, 2008 – Nice – French RivieraPe

intu

re d

e Fr

anço

ise

Pers

illon

- Im

pres

sion

Gra

phop

rint

- Par

is

affiche final 6/06/06 11:19 Page 1

• Invasive & Non-Invasive Electrophysiology • Catheter Ablation •• Pacing and Defibrillation • Heart Failure • Cardiac Imaging • Angiogenesis & Genetics •


Information: Dr Philippe Ritter • CARDIOSTIME-mail: [email protected] – Web site: www.cardiostim.fr



June 13-16, 2012 – Nice – French Riviera

Peinture

deFranço

isePersillon

-Impression

Graph

oprin

t-P

aris

EUROPEANSOCIETY OFCARDIOLOGY®

affiche final:affiche cardio 3/06/10 17:37 Page 1

www.cardiostim.com

JUNE 20-23 | NICE - FRANCE

A NEW HEART BEATS TOWARD THE FUTURE

Chairman: Dr Arnaud Lazarus | Vice President: Prof Pierre Jais - LIRYC

cardiostim 2018 -pub A5.indd 1 06/02/2017 10:04

ESC - European Society of Cardiology2035 Route des Colles, Les Templiers CS 80179 BIOT 06903 Sophia Antipolis Cedex FRANCE

For all other information please contact:

Tel.: +33 (0)4 92 94 76 00 - Fax.: +33 (0)4 92 94 76 01www.escardio.org/EHRA